Gastroesophageal reflux resistant to proton pump inhibitors;Reflux gastro-œsophagien résistant aux inhibiteurs de la pompe à protons

Hepato-Gastro

Volumn 9, Issue 3, 2002, Pages 159-163

  Galmiche, Jean Paul ^a   Sacher Huvelin, Sylvie ^a  

^a HÔTEL DIEU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BACLOFEN; CISAPRIDE; HISTAMINE H2 RECEPTOR ANTAGONIST; OMEPRAZOLE; PROKINETIC AGENT; PROTON PUMP INHIBITOR; RANITIDINE; SUCRALFATE;

ANTIREFLUX OPERATION; BILE DUCT; BILE REFLUX; DRUG TOLERANCE; EDITORIAL; ENDOSCOPIC THERAPY; ESOPHAGUS; GASTROESOPHAGEAL REFLUX; HOST RESISTANCE; HUMAN; PANCREAS; STOMACH ACID SECRETION;

EID: 0036293177     PISSN: 12537020     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (41)

1. Le reflux gastro-œsophagien de l'adulte: Quels sont les résultats des traitements médicaux?
2. An evidence based appraisal of reflux disease management - The Genval Workshop Report
3. Endoscopy-negative reflux disease
4. Long-term omeprazole treatment in resistant gastroesophageal reflux disease: Efficacy, safety, and influence on gastric mucosa
5. Management of GERD: Medical versus surgical
6. A comparison of five maintenance therapies for reflux esophagitis
7. Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: A meta-analysis
8. Prognostic factors influencing relapse of oesophagitis during maintenance therapy with antisecretory drugs: A meta-analysis of long-term omeprazole trials
9. Symptoms and disease severity in gastro-oesophageal reflux disease
10. Endoscopic assessment of esophagitis: Clinical and functional correlates and further validation of the Los Angeles classification
11. Endoscopy-negative reflux disease (ENRD)
12. French-Belgian Consensus Conference on Adult Gastro-Oesophageal Reflux Disease «Diagnosis and Treatment»
13. Cigarette smoking and gastroesophageal reflux disease
14. Mechanisms of gastro-oesophageal reflux disease (GORD) and potential targets for anti-reflux therapy
15. Relation between oesophageal acid exposure and healing of oesophagitis with omeprazole in patients with severe reflux oesophagitis
16. Reflux esophagitis in patients with Zollinger-Ellison synrome
17. Ranitidine controls nocturnal gastric acid breakthrough on omeprazole: A controlled study in normal subjects
18. Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis
19. Effect of curing Helicobacter pylori infection on intragastric pH during treatment with omeprazole
20. Helicobacter pylori infection potentiates the inhibition of gastric acid secretion by omeprazole
21. Barrett's esophagus and the role of complete acid control
22. The relationship between acid and bile reflux and symptoms in gastro-oesophageal reflux disease
23. Role of acid and duodenogastric reflux in esophageal mucosal injury: A review of animal and human studies
24. Contribution of acid and duodenogastro-oesophageal reflux to oesophageal mucosal injury and symptoms in partial gastrectomy patients
25. Duodenogastroesophageal reflux: Relationship to pH and importance in Barrett's esophagus
26. Duodenogastroesophageal reflux and esophageal mucosal injury in mechanically ventilated patients
27. Acid, nonacid, and gas reflux in patients with gastroesophageal reflux disease during ambulatory 24 hour pH-impedance recordings
28. Simultaneous intraesophageal impedance and pH measurement of acid and nonacid gastroesophageal reflux: Effect of omeprazole
29. Effects of sleeping with the bed-head raised and of ranitidine in patients with severe peptic oesophagitis
30. Oxidative stress is more important than acid in the pathogenesis of reflux
31. Why is the high grade inhibition of gastric acid secretion afforded by proton pump inhibitors often required for healing of reflux esophagitis? An epithelial perspective
32. Diagnosis of reflux disease
33. The clinical and economic value of a short course of omeprazole in patients with non-cardiac chest pain
34. 2RA therapy on nocturnal gastric acid breakthrough
35. Traitement médical du RGO par les prokinétiques
36. Transoral, flexible endoscopic suturing for treatment of GERD: A multicenter trial
37. Endoscopic implantation of plexíglas (PMMA) microspheres for the treatment of GERD
38. Radiofrequency energy delivery to the gastroesophageal junction for the treatment of GERD
39. A debate on laparoscopic anti-reflux surgery in gastro-oesophageal reflux disease: Antagonist view
40. Bagonist baclofen in patients with gastro-oesophageal reflux disease
41. Anti-relaxation therapy in GORD